Nicola Kenealy
BSc. Hons
Senior Trial Manager
I have been working in the Primary Care Clinical Trial Unit since May 2022, where I am a Senior Trial Manager overseeing the following studies:
- RESTED
- STARCAT
- OPTIMISE 2
- TOUCAN
- SNAP2
- TRIDENT
- EVOLUTION
Before joining Primary Care I worked at NDORMS for 8 years as a Trial Manager and before that for 3 years as a Trial Coordinator at OCTO.
Recent publications
plaTform fOr Urinary tract infection diagnostiC evAluatioN (TOUCAN): a protocol for a prospective diagnostic accuracy study of point-of-care testing in patients suspected of acute uncomplicated urinary tract infection in primary care clinics in England
Journal article
Turner PJ. et al, (2025), BMJ Open, 15
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Journal article
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
Journal article
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL
Journal article
Sheppard J. et al, (2024), JOURNAL OF HYPERTENSION, 42
nti-TNF (adalimumab) injection for the treatment of adults with frozen shoulder during the pain predominant stage protocol for a multi-centre, randomised, double blind, parallel group, feasibility trial
Journal article
Hopewell S. et al, (2023), NIHR Open Research, 2